Brainsway Ltd. Operating Income 2011-2025 | BWAY

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Brainsway Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-5 M	-4.83 M	-8.48 M	-5.11 M	-6.61 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-4.83 M	-8.48 M	-6.01 M

Operating Income of other stocks in the Diagnostics research industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Akumin AKU	-28.1 M	-	-17.87 %	$ 25.9 M	Canada
Centogene N.V. CNTG	-46 M	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	-797 M	$ 20.37	-4.19 %	$ 220 M	China
Accelerate Diagnostics AXDX	-14 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	-32 M	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	-23.6 M	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	-42.7 M	$ 0.23	-4.53 %	$ 6.75 M	USA
Castle Biosciences CSTL	8.67 M	$ 39.55	-1.35 %	$ 1.1 B	USA
BioNano Genomics BNGO	-104 M	$ 1.51	-0.99 %	$ 1.92 M	USA
DarioHealth Corp. DRIO	-56.2 M	$ 10.11	0.67 %	$ 287 M	Israel
DexCom DXCM	598 M	$ 67.29	-0.2 %	$ 26 B	USA
Danaher Corporation DHR	4.86 B	$ 229.74	-0.56 %	$ 168 B	USA
Exact Sciences Corporation EXAS	-876 M	$ 101.64	0.1 %	$ 18.8 B	USA
Enzo Biochem ENZ	-12.4 M	-	-8.98 %	$ 14.8 K	USA
Fulgent Genetics FLGT	-73.9 M	$ 26.73	-1.04 %	$ 808 M	USA
Global Cord Blood Corporation CO	609 M	-	-	$ 399 M	China
Genetron Holdings Limited GTH	-518 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-104 M	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	-203 M	$ 19.42	-1.57 %	$ 1.04 B	USA
Celcuity CELC	-113 M	$ 102.35	-0.25 %	$ 4.04 B	USA
Anixa Biosciences ANIX	-13.8 M	$ 3.22	-5.85 %	$ 103 K	USA
Heska Corporation HSKA	-20.3 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-20.8 M	-	-20.0 %	$ 1.06 M	USA
IQVIA Holdings IQV	2.2 B	$ 226.16	0.1 %	$ 41 B	USA
Guardant Health GH	-444 M	$ 104.05	1.63 %	$ 12.8 B	USA
Aspira Women's Health AWH	-32.8 M	-	-6.19 %	$ 10.5 M	USA
Illumina ILMN	-833 M	$ 134.84	-0.36 %	$ 21.4 B	USA
Charles River Laboratories International CRL	227 M	$ 202.86	-0.51 %	$ 10.4 B	USA
Myriad Genetics MYGN	-124 M	$ 6.44	-1.68 %	$ 583 M	USA
ENDRA Life Sciences NDRA	-10.8 M	$ 5.0	-1.96 %	$ 2.68 M	USA
Neogen Corporation NEOG	-1.06 B	$ 7.06	-1.12 %	$ 1.53 B	USA
Quest Diagnostics Incorporated DGX	1.35 B	$ 176.11	0.13 %	$ 19.5 B	USA
Biodesix BDSX	-34.5 M	$ 6.66	-2.35 %	$ 864 M	USA
National Research Corporation NRC	40 M	$ 18.55	-0.54 %	$ 455 M	USA
Motus GI Holdings MOTS	-11.9 M	-	-34.28 %	$ 263 K	Israel
Laboratory Corporation of America Holdings LH	1.09 B	$ 253.72	-0.22 %	$ 21.3 B	USA
ICON Public Limited Company ICLR	1.1 B	$ 181.45	-1.22 %	$ 15 B	Irlanda
IDEXX Laboratories IDXX	1.13 B	$ 687.47	-0.1 %	$ 56.7 B	USA
Lantheus Holdings LNTH	457 M	$ 66.38	-0.45 %	$ 4.59 B	USA
Agilent Technologies A	1.35 B	$ 138.03	-0.17 %	$ 42 B	USA
Biomerica BMRA	-5.14 M	$ 2.77	4.52 %	$ 6.36 M	USA
Bioventus BVS	-81.7 M	$ 7.41	0.35 %	$ 464 M	USA
Pacific Biosciences of California PACB	-334 M	$ 1.78	-5.32 %	$ 451 M	USA
NeoGenomics NEO	-92.1 M	$ 12.37	0.57 %	$ 1.57 B	USA